Fed Circuit dismisses Hospira appeal, says it must pay Amgen $70m

17-12-2019

Saman Javed

Fed Circuit dismisses Hospira appeal, says it must pay Amgen $70m

Pavel Kapysh / Shutterstock.com

A subsidiary of Pfizer, Hospira, infringed one of Amgen’s patents and must pay damages of $70 million, the US Court of Appeal for the Federal Circuit has affirmed.


Pfizer, Hospira, US Court of Appeal for the Federal Circuit, US District Court for the District of Delaware, biologic, patent infringement

More on this story

Pfizer and Sun settle Bosulif dispute
06-11-2019

LSIPR